Views & Analysis Combating antimicrobial resistance with a viable alternative... Antimicrobial resistance (AMR) is an issue of global concern, killing roughly 1.2 million1 people per year and projected to rise to
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.